From skeletal to cardiovascular disease in 12 steps—the evolution of sclerostin as a major player in CKD-MBD
Crossref DOI link: https://doi.org/10.1007/s00467-015-3069-7
Published Online: 2015-03-04
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Brandenburg, Vincent M.
D’Haese, Patrick
Deck, Annika
Mekahli, Djalila
Meijers, Björn
Neven, Ellen
Evenepoel, Pieter
Text and Data Mining valid from 2015-03-04